In a recent study by Pan et al., a CTLA4-PD-L1 chimeric protein vaccine (protein vaccine) was constructed, which may function as a therapeutic and preventive cancer vaccine in TAA-induced iCCA rat models (118). Here, CTLA4 is linked to cancer.